检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王以平 都静 龚帅[1] WANG Yiping;DU Jing;GONG Shuai(The First Affiliated Hospital of Zhengzhou University,Zhengzhou,450000)
机构地区:[1]郑州大学第一附属医院,450000
出 处:《实用癌症杂志》2023年第7期1145-1147,1151,共4页The Practical Journal of Cancer
摘 要:目的探讨立体定向放疗Ⅰ期非小细胞肺癌(NSCLC)患者的生存质量及预后相关影响因素。方法回顾性分析接受立体定向放疗的98例Ⅰ期NSCLC患者临床资料。比较患者放射前、放射后3个月生活质量差异,并分析影响立体定向放疗对Ⅰ期NSCLC患者预后的相关因素。结果放疗后呼吸困难、焦虑或抑郁发生率低于放疗前,差异有统计学意义(P<0.05);放疗前、后躯体功能、失眠、咳嗽、食欲减退、疲倦发生率比较,差异无统计学意义(P>0.05)。Ⅰ期NSCLC放疗后5年生存率为53.06%(52/98),单因素分析显示:年龄、肿瘤直径、临床分期、治疗缓解情况与立体定向放疗Ⅰ期NSCLC患者预后相关,差异有统计学意义(P<0.05);多因素分析显示:年龄≥60岁、肿瘤直径>3 cm、临床ⅠB期、治疗未缓解是立体定向放疗Ⅰ期NSCLC患者预后的高危因素(P<0.05)。结论立体定向放疗可有效提高Ⅰ期NSCLC患者生存质量,年龄、肿瘤直径、临床分期、治疗缓解情况是患者预后的影响因素。Objective To investigate the factors of stereoradiotherapy in stageⅠnon-small cell lung cancer(NSCLC).Methods The clinical data of 98 patients with stageⅠNSCLC treated with stereotactic radiotherapy were retrospectively analyzed.Quality of life before and 3 months after radiation were compared,and analyzed the prognostic factors of stereotactic radiotherapy on patients with stageⅠNSCLC.Results Lower rates of dyspnea,anxiety,or depression after radiation than before radiation,The difference was statistical significant(P<0.05);Comparison of incidence before and after physical function,insomnia,cough,loss of appetite,and fatigue,The difference was not significantly significant(P>0.05);The 5-year survival rate after phaseⅠNSCLC radiation was 53.06%(52/98),Univariate analysis showed that age,tumor diameter,clinical stage,and treatment without remission were related to the prognostic impact of stereotactic radiotherapy on patients with stageⅠNSCLC,The difference was statistical significant(P<0.05);Multivariate analysis showed that:age 60 years old,tumor diameter>3 cm,clinical stageⅠB,and treatment remission were high-risk factors of stereotactic radiotherapy on stageⅠNSCLC patients(P<0.05).Conclusion Steretactic radiotherapy can effectively improve the quality of survival of patients with stageⅠNSCLC,and age,tumor diameter,clinical stage and treatment remission are high risk factors affecting patient prognosis.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.116.118.216